1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. ChenGuang Biotech Group Co., Ltd.
  6. Summary
    300138   CNE100000WC5

CHENGUANG BIOTECH GROUP CO., LTD.

(300138)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-17
14.89 CNY   -1.39%
06/02Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agricultural Technology Co., Ltd. from ChenGuang Biotech Group Co., Ltd. and Xinjiang Chenxi Pepper Industry Co., Ltd. for CNY 88.3 million.
CI
05/25Chenguang Biotech Group Co., Ltd. Announces 2021 Final Cash Dividend Proposal on A Shares, Payable on 1 June 2022
CI
04/27UBS Adjusts ChenGuang Biotech's Price Target to 21.50 Yuan From 20.80 Yuan, Keeps at Buy
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
08/12/2022 08/15/2022 08/16/2022 08/17/2022 08/18/2022 Date
15 15.13 15.01 15.1 14.89 Last
3025605 3348170 3932891 4206825 4089211 Volume
-0.92% +0.87% -0.79% +0.60% -1.39% Change
Estimated financial data (e)
Sales 2022 6 493 M 957 M 957 M
Net income 2022 458 M 67,5 M 67,5 M
Net Debt 2022 1 684 M 248 M 248 M
P/E ratio 2022 17,3x
Yield 2022 1,13%
Sales 2023 7 464 M 1 100 M 1 100 M
Net income 2023 563 M 82,9 M 82,9 M
Net Debt 2023 1 710 M 252 M 252 M
P/E ratio 2023 14,0x
Yield 2023 1,42%
Capitalization 7 933 M 1 169 M 1 169 M
EV / Sales 2022 1,48x
EV / Sales 2023 1,29x
Nbr of Employees 1 351
Free-Float 22,5%
More Financials
Company
Chenguang Biotech Group Co., Ltd. is a China-based company principally engaged in the manufacture and sales of natural pigment extracts, natural spices extracts, essential oil extracts, natural supplement and medicine extracts, fat and protein and others. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The Company distributes its products in... 
Sector
Food Processing
Calendar
08/23Earnings Release
More about the company
Ratings of ChenGuang Biotech Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about CHENGUANG BIOTECH GROUP CO., LTD.
06/02Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agric..
CI
05/25Chenguang Biotech Group Co., Ltd. Announces 2021 Final Cash Dividend Proposal on A Shar..
CI
04/27UBS Adjusts ChenGuang Biotech's Price Target to 21.50 Yuan From 20.80 Yuan, Keeps at Bu..
MT
04/25ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended ..
CI
04/20Chenguang Biotech Group Co., Ltd. Approves Cash Dividend
CI
03/30UBS Adjusts Chenguang Biotech Group's Price Target to 20.8 Yuan From 19, Keeps at Buy
MT
03/29ChenGuang Biotech Group Co., Ltd. Announces Final Dividend For the Year 2021
CI
02/28ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended Dece..
CI
2021Chenguang Biotech Group Handan Co., Ltd. announced that it has received CNY 150 million..
CI
2021Hebei ChenGuang Pharmaceutical Co., Ltd. announced that it has received CNY 81 million ..
CI
2021Hebei ChenGuang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 81 mi..
CI
2021Chenguang Biotech Group Handan Co., Ltd. announced that it expects to receive CNY 150 m..
CI
2021ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended Se..
CI
2021Chenguang Biotech Says Unit Plans Listing in China's Third Board
CI
2021CHENGUANG BIOTECH GROUP CO., LTD.(XS : 300138) added to S&P Global BMI Index
CI
More news
News in other languages on CHENGUANG BIOTECH GROUP CO., LTD.
05/25Chenguang Biotech Group Co., Ltd. annonce une proposition de dividende final en espèces..
04/25ChenGuang Biotech Group Co., Ltd. annonce ses résultats pour le premier trimestre se te..
04/20Chenguang Biotech Group Co., Ltd. approuve le dividende en espèces
03/29ChenGuang Biotech Group Co., Ltd. annonce le dividende final pour l'année 2021
02/28ChenGuang Biotech Group Co., Ltd. annonce ses résultats pour l'année complète se termin..
More news
Analyst Recommendations on CHENGUANG BIOTECH GROUP CO., LTD.
More recommendations
Chart CHENGUANG BIOTECH GROUP CO., LTD.
Duration : Period :
ChenGuang Biotech Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHENGUANG BIOTECH GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 14,89 CNY
Average target price 20,83 CNY
Spread / Average Target 39,9%
EPS Revisions
Managers and Directors
Qing Guo Lu Chairman & General Manager
Jing Zhou Chief Financial Officer & Director
Wei Gao Chairman-Supervisory Board
Zhang Lin Liu Independent Director
Shu Hong Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CHENGUANG BIOTECH GROUP CO., LTD.-10.84%1 169
NESTLÉ S.A.-8.30%338 291
MONDELEZ INTERNATIONAL, INC.-1.15%89 786
ARCHER-DANIELS-MIDLAND COMPANY29.63%48 404
THE HERSHEY COMPANY19.22%47 245
THE KRAFT HEINZ COMPANY6.57%46 812